Ads
related to: drug replacement for coumadin 20
Search results
Results From The WOW.Com Content Network
Ximelagatran (Exanta or Exarta, H 376/95) is an anticoagulant that has been investigated extensively as a replacement for warfarin [1] that would overcome the problematic dietary, drug interaction, and monitoring issues associated with warfarin therapy.
Dabigatran is an oral direct thrombin inhibitor. Dabigatran (Pradaxa) was found to be noninferior to Warfarin in prevention of ischemic stroke, as well as intracranial hemorrhage risk and overall mortality for non-valvular atrial fibrillation according to the RE-LY trial. [9]
The risk of bleeding is increased if used at the same time as other blood thinning drugs such as nonsteroidal anti-inflammatory drugs, antiplatelet drugs and heparin. [2] The blood thinning effects can be reduced if used at the same time as rifampicin and phenytoin , and increased with fluconazole .
[8] [9] [10] It is used as an alternative to warfarin to prevent blood clots following hip or knee replacement and in those with a history of prior clots [8] [10] and does not require monitoring by blood tests [8] or dietary restrictions. [11] It is taken by mouth. [8] Common side effects include bleeding and nausea.
Dabigatran is used to prevent strokes in those with atrial fibrillation not caused by heart valve issues, as well as deep vein thrombosis and pulmonary embolism in persons who have been treated for 5–10 days with parenteral anticoagulant (usually low molecular weight heparin), and to prevent deep vein thrombosis and pulmonary embolism in some circumstances.
The Watchman procedure helps those with atrial fibrillation (AFib). Medicare covers the surgery for eligible beneficiaries. AFib is a common heart rhythm disorder consisting of rapid and irregular ...